NASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis $7.58 +0.45 (+6.31%) As of 01:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Nutriband Stock (NASDAQ:NTRB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nutriband alerts:Sign Up Key Stats Today's Range$6.92▼$7.7850-Day Range$6.22▼$10.7252-Week Range$3.72▼$11.78Volume3.06 million shsAverage Volume146,992 shsMarket Capitalization$84.52 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingBuy Company Overview Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Read More Nutriband Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreNTRB MarketRank™: Nutriband scored higher than 61% of companies evaluated by MarketBeat, and ranked 473rd out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingNutriband has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNutriband has received no research coverage in the past 90 days.Read more about Nutriband's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Nutriband are expected to grow in the coming year, from ($0.60) to ($0.56) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nutriband is -8.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nutriband is -8.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNutriband has a P/B Ratio of 13.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Nutriband's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.10% of the float of Nutriband has been sold short.Short Interest Ratio / Days to CoverNutriband has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutriband has recently decreased by 12.91%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNutriband does not currently pay a dividend.Dividend GrowthNutriband does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.10% of the float of Nutriband has been sold short.Short Interest Ratio / Days to CoverNutriband has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutriband has recently decreased by 12.91%, indicating that investor sentiment is improving significantly. News and Social Media1.6 / 5News Sentiment-0.13 News SentimentNutriband has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.37 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Nutriband this week, compared to 1 article on an average week.MarketBeat Follows2 people have added Nutriband to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nutriband insiders have not sold or bought any company stock.Percentage Held by Insiders54.09% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.70% of the stock of Nutriband is held by institutions.Read more about Nutriband's insider trading history. Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Email Address NTRB Stock News HeadlinesNutriband Inc.: FDA Grants Nutriband Meeting Request for Aversa Fentanyl Abuse Deterrent Fentanyl Patch4 hours ago | finanznachrichten.deNutriband stock rises after FDA grants meeting for fentanyl patch4 hours ago | au.investing.comGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.August 8 at 2:00 AM | Priority Gold (Ad)FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch4 hours ago | finance.yahoo.comNutriband Shares Climb After FDA Grants Meeting for Fentanyl Patch4 hours ago | msn.comFDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl PatchAugust 8 at 8:00 AM | globenewswire.comNutriband (NASDAQ: NTRB): Innovation Meets Science Through Scalable PlatformJuly 29, 2025 | theglobeandmail.comNutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA ApprovalJuly 18, 2025 | globenewswire.comSee More Headlines NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed this year? Nutriband's stock was trading at $4.71 at the beginning of the year. Since then, NTRB shares have increased by 62.0% and is now trading at $7.63. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) posted its quarterly earnings results on Friday, May, 30th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.01. The business had revenue of $0.67 million for the quarter, compared to analyst estimates of $0.71 million. Nutriband had a negative trailing twelve-month return on equity of 68.25% and a negative net margin of 415.93%. When did Nutriband's stock split? Nutriband shares split on the morning of Monday, August 15th 2022.The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were distributed to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. Who are Nutriband's major shareholders? Top institutional shareholders of Nutriband include Consolidated Portfolio Review Corp (0.09%). How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nutriband own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nutriband investors own include Jiuzi (JZXN), AMC Entertainment (AMC), Aridis Pharmaceuticals (ARDS), Avenue Therapeutics (ATXI), Esports Entertainment Group (GMBL), Moleculin Biotech (MBRX) and ARMOUR Residential REIT (ARR). Company Calendar Last Earnings5/30/2025Today8/08/2025Next Earnings (Estimated)9/02/2025Fiscal Year End1/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNASDAQ:NTRB CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees10Year FoundedN/APrice Target and Rating Average Price Target for Nutriband$13.00 High Price Target$13.00 Low Price Target$13.00 Potential Upside/Downside+82.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($0.90) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.48 million Net Margins-415.93% Pretax Margin-415.93% Return on Equity-68.25% Return on Assets-60.40% Debt Debt-to-Equity Ratio0.01 Current Ratio3.71 Quick Ratio3.48 Sales & Book Value Annual Sales$2.14 million Price / Sales37.15 Cash FlowN/A Price / Cash FlowN/A Book Value$0.58 per share Price / Book12.29Miscellaneous Outstanding Shares11,150,000Free Float5,121,000Market Cap$79.50 million OptionableNot Optionable Beta1.13 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:NTRB) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly tak...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.